Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer

Bibliographic Details
Main Authors: Ravi K. Anchoori, Rosie Jiang, Shiwen Peng, Ruey-shyang Soong, Aliyah Algethami, Michelle A. Rudek, Nicole Anders, Chien-Fu Hung, Xiang Chen, Xiuxiu Lu, Olumide Kayode, Marzena Dyba, Kylie J. Walters, Richard B. S. Roden
Format: Article
Language:English
Published: American Chemical Society 2018-09-01
Series:ACS Omega
Online Access:http://dx.doi.org/10.1021/acsomega.8b01479
_version_ 1818432711820312576
author Ravi K. Anchoori
Rosie Jiang
Shiwen Peng
Ruey-shyang Soong
Aliyah Algethami
Michelle A. Rudek
Nicole Anders
Chien-Fu Hung
Xiang Chen
Xiuxiu Lu
Olumide Kayode
Marzena Dyba
Kylie J. Walters
Richard B. S. Roden
author_facet Ravi K. Anchoori
Rosie Jiang
Shiwen Peng
Ruey-shyang Soong
Aliyah Algethami
Michelle A. Rudek
Nicole Anders
Chien-Fu Hung
Xiang Chen
Xiuxiu Lu
Olumide Kayode
Marzena Dyba
Kylie J. Walters
Richard B. S. Roden
author_sort Ravi K. Anchoori
collection DOAJ
first_indexed 2024-12-14T16:09:33Z
format Article
id doaj.art-ddb3d390b0824e9bb143313880ac9c72
institution Directory Open Access Journal
issn 2470-1343
language English
last_indexed 2024-12-14T16:09:33Z
publishDate 2018-09-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj.art-ddb3d390b0824e9bb143313880ac9c722022-12-21T22:55:01ZengAmerican Chemical SocietyACS Omega2470-13432018-09-0139119171192910.1021/acsomega.8b01479Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian CancerRavi K. Anchoori0Rosie Jiang1Shiwen Peng2Ruey-shyang Soong3Aliyah Algethami4Michelle A. Rudek5Nicole Anders6Chien-Fu Hung7Xiang Chen8Xiuxiu Lu9Olumide Kayode10Marzena Dyba11Kylie J. Walters12Richard B. S. Roden13†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States∇Biophysics Resource, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United Stateshttp://dx.doi.org/10.1021/acsomega.8b01479
spellingShingle Ravi K. Anchoori
Rosie Jiang
Shiwen Peng
Ruey-shyang Soong
Aliyah Algethami
Michelle A. Rudek
Nicole Anders
Chien-Fu Hung
Xiang Chen
Xiuxiu Lu
Olumide Kayode
Marzena Dyba
Kylie J. Walters
Richard B. S. Roden
Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
ACS Omega
title Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
title_full Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
title_fullStr Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
title_full_unstemmed Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
title_short Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
title_sort covalent rpn13 binding inhibitors for the treatment of ovarian cancer
url http://dx.doi.org/10.1021/acsomega.8b01479
work_keys_str_mv AT ravikanchoori covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT rosiejiang covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT shiwenpeng covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT rueyshyangsoong covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT aliyahalgethami covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT michellearudek covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT nicoleanders covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT chienfuhung covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT xiangchen covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT xiuxiulu covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT olumidekayode covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT marzenadyba covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT kyliejwalters covalentrpn13bindinginhibitorsforthetreatmentofovariancancer
AT richardbsroden covalentrpn13bindinginhibitorsforthetreatmentofovariancancer